Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Type II Diabetes Mellitus III: Clinical Manifestations and Diagnosis01:25

Type II Diabetes Mellitus III: Clinical Manifestations and Diagnosis

Type 2 diabetes mellitus develops gradually and is often asymptomatic in early stages.Clinical ManifestationsWhen symptoms appear, they include fatigue, blurred vision, pruritus, delayed wound healing, and recurrent infections, particularly candidal infections. Peripheral neuropathy may present as numbness or tingling in the extremities. Classic hyperglycemia symptoms—polyuria, polydipsia, and polyphagia—are less common. Most patients are overweight and frequently have associated hypertension...
Diabetes Mellitus: Type 2 and Gestational01:22

Diabetes Mellitus: Type 2 and Gestational

Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
Type II Diabetes I: Introduction01:26

Type II Diabetes I: Introduction

Type 2 diabetes mellitus (T2DM) is a chronic metabolic disorder characterized by insulin resistance, in which target tissues such as the liver, muscle, and adipose tissue respond poorly to insulin. It is also associated with inadequate compensatory insulin secretion, where pancreatic β-cells fail to produce sufficient insulin. Together, these abnormalities lead to persistent hyperglycemia.EtiologyT2DM develops through a complex interaction of genetic predisposition and environmental or...
Diabetes: Symptoms, Diagnosis, and Complications01:15

Diabetes: Symptoms, Diagnosis, and Complications

For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is based on...
Type I Diabetes I: Introduction01:12

Type I Diabetes I: Introduction

Type 1 diabetes mellitus is a chronic metabolic disorder characterized by an absolute deficiency of insulin resulting from the autoimmune destruction of pancreatic β-cells. Although it can occur at any age, it is most commonly diagnosed in childhood, adolescence, or early adulthood. The loss of insulin production impairs cellular glucose uptake, resulting in persistent hyperglycemia and necessitating lifelong insulin therapy.Autoimmune Destruction of β-CellsThe hallmark of type 1 diabetes is an...
Type II Diabetes II: Pathophysiology01:24

Type II Diabetes II: Pathophysiology

PathophysiologyType 2 diabetes mellitus (T2DM ) is a chronic metabolic disorder characterized by insulin resistance and progressive pancreatic β-cell dysfunction, leading to impaired glucose homeostasis. It results from interactions among genetic predisposition, environmental factors, and metabolic stressors, such as overnutrition and a sedentary lifestyle.Insulin Resistance and Glucose DysregulationEarly T2DM involves insulin resistance in skeletal muscle, adipose tissue, and the liver.

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Adherence to Healthy and Sustainable Dietary Patterns and Long-Term Chronic Inflammation: Data from the EPIC-Potsdam Cohort.

The journal of nutrition, health & aging·2023
Same author

Metabolically defined body size and body shape phenotypes and risk of postmenopausal breast cancer in the European Prospective Investigation into Cancer and Nutrition.

Cancer medicine·2023
Same author

Dietary fatty acids and endometrial cancer risk within the European Prospective Investigation into Cancer and Nutrition.

BMC cancer·2023
Same author

Dihydroceramide- and ceramide-profiling provides insights into human cardiometabolic disease etiology.

Nature communications·2022
Same author

[German Society of Medical Intensive Care and Emergency Medicine mourns the death of Angela Aey].

Medizinische Klinik, Intensivmedizin und Notfallmedizin·2022
Same author

Milk intake and incident stroke and CHD in populations of European descent: a Mendelian randomisation study.

The British journal of nutrition·2021

Related Experiment Video

Updated: May 12, 2026

Glycemic Impact on Knee Osteoarthritis Symptoms on Physical, Radiographic, and Inflammatory Markers among Individuals Aged 50 and Over with Diabetes
07:22

Glycemic Impact on Knee Osteoarthritis Symptoms on Physical, Radiographic, and Inflammatory Markers among Individuals Aged 50 and Over with Diabetes

Published on: March 7, 2025

Validation of the German Diabetes Risk Score within a population-based representative cohort.

S Hartwig1, O Kuss, D Tiller

  • 1Institute of Medical Epidemiology, Biostatistics, and Informatics, Martin-Luther-University Halle-Wittenberg, Halle (Saale), Germany. Saskia.Hartwig@uk-halle.de

Diabetic Medicine : a Journal of the British Diabetic Association
|April 17, 2013
PubMed
Summary

The German Diabetes Risk Score showed a high indication of increased diabetes risk in the CARLA study. However, its predictive accuracy was limited, suggesting potential cohort differences and model overfit in previous studies.

Related Experiment Videos

Last Updated: May 12, 2026

Glycemic Impact on Knee Osteoarthritis Symptoms on Physical, Radiographic, and Inflammatory Markers among Individuals Aged 50 and Over with Diabetes
07:22

Glycemic Impact on Knee Osteoarthritis Symptoms on Physical, Radiographic, and Inflammatory Markers among Individuals Aged 50 and Over with Diabetes

Published on: March 7, 2025

Area of Science:

  • Epidemiology
  • Public Health
  • Diabetes Research

Background:

  • The German Diabetes Risk Score (GDRS) is used to assess diabetes risk.
  • Validation of risk scores in diverse populations is crucial for accurate diabetes prediction.

Purpose of the Study:

  • To validate the GDRS in the population-based Cardiovascular Disease - Living and Ageing in Halle (CARLA) study.
  • To assess the predictive performance of the GDRS and explore improvements.

Main Methods:

  • The study included 1301 participants (582 women, 719 men, aged 45-83) without diabetes at baseline.
  • The GDRS was applied, and predictions were compared to observed diabetes incidence over 4 years.
  • Statistical analyses included Hosmer-Lemeshow tests and receiver-operator characteristic (ROC) analyses.

Main Results:

  • The median 4-year diabetes risk was 6.5%. The GDRS showed a poor fit (p=5.8*10⁻¹²).
  • The area under the ROC curve (AUC) was 0.70, increasing to 0.77 when excluding older participants (≥66 years).
  • Models incorporating blood glucose (AUC 0.81) or HbA1c (AUC 0.84) demonstrated improved predictive performance.

Conclusions:

  • The GDRS validation in the CARLA cohort did not fully replicate previous findings, possibly due to cohort differences or model overfit.
  • Despite limitations, a high GDRS score remains indicative of an elevated diabetes risk.
  • Integrating metabolic variables like blood glucose or HbA1c significantly enhances the predictive power for diabetes incidence.